High target disease prevalence, product launches, increasing strategic developments such as partnerships and agreements, favourable research funding scenario, and development of advanced genomic analysis techniques for quality control during implant manufacturing are key factors contributing to high CAGR of Extremities (Shoulder and Small Combined Implants) during forecast period.
According to the current analysis of Reports and Data, the Global Extremities (Shoulder and Small Combined Implants) Market was valued at USD 2.27 Billion in 2020 and is expected to reach USD 3.82 Billion by year 2026, at a CAGR of 6.8%.
The Extremities market is a compact portion of the orthopedic industry which is driven by the rise in procedures for orthopedic, surgeons due to an increase in ageing population and high global awareness for better treatment for such a high cost.
Patients recover quickly due to advancements in technology and due to the introduction of robotics and 3D printing. Development of new shoulder and ankles and less invasive devices have driven the growth in this market. The restraint such as high manufacturing cost of these operations are pressurising hospitals a lot to opt for the procedures at a very low cost is draining the growth of this market.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC])@ https://www.reportsanddata.com/sample-enquiry-form/1415
The report provides comprehensive assessment of the market covering key elements such as revenue estimations, cost analysis, import/export, production and consumption trends, CAGR, gross margin, and supply demand patterns. It also sheds light on recent technological developments, product advancements, and research and development activities in the region.
The report examines the key players operating in the market along with their market position, market share, revenue, gross margin, and business strategies. SWOT analysis and Porter’s Five Forces Analysis are used to examine and assess the market and its players. It also covers recent mergers and acquisitions, combined ventures, collaborations, agreements, partnerships, and product launches and brand promotions.
Key companies profiled in the report include:
Johnson Johnson, Smith Nephew, Stryker, Wright Medical and Zimmer Biomet
Market Segmentation by Types:
Product Type: (Revenue, USD Million; 2020–2028)
- Upper Extremity Devices
- Shoulder
- Elbow
- Hand and Wrist
- Others
- Lower Extremity Devices
- Foot
- Ankle
- Others
Material: (Revenue, USD Million; 2020–2028)
- Ceramics
- Metallic
- Polymeric
End Use: (Revenue, USD Million; 2020–2028)
- Hospitals
- Ambulatory Surgical Centres (ASC’s)
- Pharmaceutical and Biotech Companies
- Orthopedic Clinics
- Others
Order this Report @ https://www.reportsanddata.com/report-pricing/1415
Regional analysis covers in-depth analysis of analysis of the revenue, market share, and growth rate of the global Extremities (Shoulder and Small Combined Implants) market in each region for the forecast period of 2021-2028. The report covers production and consumption rate, current and emerging trends, import/export, supply and demand, and presence of key players in each region.
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Further key findings from the report suggest:
- Elbow type segment is the growing at a CAGR of 6.3% during the forecasted years of 2019-2026 and accounted a market share of 19.2%
- Extremities Market is fastest growing at a CAGR of 9% in Asia Pacific followed by North America respectively owing to increasing cases of obesity and bone disorders related to it
- Upper Extremity Devices has the dominated the market with a share of 67.9% in 2020 due to high occurrence of orthopedic disorders in shoulders
- Orthopedic clinics are projected to be the fastest expanding end-users in this market at a CAGR of 7.2%
- Revenues from ambulatory surgical centres will increase at a CAGR lower than those from orthopedic clinics and hospitals i.e. 6.2% through 2026
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1415
Thank you for reading our report. For further inquiry, please connect with us and our team will make sure the report is customized according to your requirements.
Explore More Industry Research by Reports and Data:
Digital Pathology Market @ https://cse.google.co.uz/url?q=https://www.biospace.com/article/digital-pathology-market-size-2022-2030-increasing-adoption-of-digital-pathology-to-enhance-lab-efficiency/
Cinitapride Market @ https://cse.google.co.uz/url?q=https://www.biospace.com/article/cinitapride-market-analysis-industry-size-share-leaders-current-status-by-major-key-vendors-and-trends-by-forecast-to-2028/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
